Cargando…
Clinical and research applications of a brain tumor tissue bank in the age of precision medicine
Marked progress has been made recently in the treatment of patients with central nervous system (CNS) tumors, especially gliomas. However, because of the relative rarity of these tumors compared with other malignancies, advances in the molecular/genetic analysis leading to future targeted treatments...
Autores principales: | Snyder, James, Poisson, Laila M, Noushmehr, Houtan, Castro, Ana V, deCarvalho, Ana C, Robin, Adam, Mukherjee, Abir, Lee, Ian, Walbert, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598053/ https://www.ncbi.nlm.nih.gov/pubmed/30816054 http://dx.doi.org/10.2217/pme-2018-0102 |
Ejemplares similares
-
OTME-5. Meningioma liquid biopsy specimens exhibit contrasting immune-cell landscapes across methylation-subtypes and estimated recurrence risk subgroups
por: Herrgott, Grayson, et al.
Publicado: (2021) -
OR32-03 Serum Cell-Free Methylation-Based Signatures Distinguishes Pituitary Tumors According to Functional Status and from Other Neoplasia: A Liquid Biopsy Approach
por: Wells, Michael, et al.
Publicado: (2020) -
MLTI-05. IDENTIFYING BRAIN METASTATIC CASES FROM FREE TEXT CLINICAL NARRATIVES WITH REFINEMENT OF SEMANTIC HETEROGENEITY USING MACHINE LEARNING
por: Wells, Michael, et al.
Publicado: (2019) -
OR24-5 Aberrant DNA Methylation in Regulatory Genomic Elements Are Associated with Invasive Behavior of Pituitary Macroadenomas: An Integrative Analysis of Epigenome-Wide Studies
por: Mosella, Maritza, et al.
Publicado: (2019) -
Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors
por: Herrgott, Grayson A, et al.
Publicado: (2022)